Skip to content

Kodiak Sciences Inc KOD Other Working Capital

Other Working Capital at other companies

Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$1M-200%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
-$214K-296%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$1M
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-$2.15M-410%
Roivant Sciences logo
Roivant SciencesROIV
-$8.3M-230%
Bausch + Lomb logo
Bausch + LombBLCO
$0-100%

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.32B+1,477%
Enterprise value$2.2B+2,798%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:OtherOperatingActivitiesCashFlowStatement.

The official record: Kodiak Sciences Inc’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kodiak Sciences Inc's other working capital?
Kodiak Sciences Inc (KOD) reported other working capital of $5K in Q4 2025.
What is the long-term trend for Kodiak Sciences Inc's other working capital?
Over 2 years (2023 to 2025), Kodiak Sciences Inc's other working capital has grown at a 82.6% compound annual growth rate (CAGR), from $6K to $20K.
What does other working capital mean?
Net change in working capital items not separately classified — a residual balancing item.